Adel Kardosh
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Physiology top 5%
- Adenosine and Purinergic Signaling
Papers in
- Oncology 41
- Colorectal Cancer Treatments and Studies 16
- Pancreatic and Hepatic Oncology Research 9
-
- Gastric Cancer Management and Outcomes 9
- Co-authors
- Axel H. Schönthal (17 shared papers)Thomas C. Chen (12 shared papers)Nicos A. Petasis (8 shared papers)Peter Pyrko (6 shared papers)Florence M. Hofman (8 shared papers)Jasim Uddin (5 shared papers)Stan G. Louie (4 shared papers)Encouse B. Golden (3 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Annals of Oncology (6 papers)Annals of Surgical Oncology (4 papers)Cancer Biology & Therapy (2 papers)Blood (2 papers)
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Adel Kardosh
72 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 95
- Pharmacology 259
- Physiology 75
- Oncology 346
- Applied Microbiology and Biotechnology 25
- Cell Biology 200
Countries citing papers authored by Adel Kardosh
This map shows the geographic impact of Adel Kardosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Kardosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Kardosh more than expected).
Fields of papers citing papers by Adel Kardosh
This network shows the impact of papers produced by Adel Kardosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Kardosh. The network helps show where Adel Kardosh may publish in the future.
Co-authors
The 25 scholars most cited alongside Adel Kardosh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 206 | |
| 2 | 2008 | 112 | |
| 3 | 2007 | 111 | |
| 4 | 2007 | 110 | |
| 5 | 2006 | 78 | |
| 6 | 2005 | 74 | |
| 7 | 2004 | 71 | |
| 8 | 2008 | 60 | |
| 9 | 2005 | 53 | |
| 10 | 2018 | 49 | |
| 11 | 2020 | 45 | |
| 12 | 2006 | 42 | |
| 13 | 2018 | 37 | |
| 14 | 2023 | 28 | |
| 15 | 2014 | 26 | |
| 16 | 2007 | 26 | |
| 17 | 2021 | 25 | |
| 18 | 2007 | 21 | |
| 19 | 2014 | 19 | |
| 20 | 2010 | 19 |
About Adel Kardosh
Adel Kardosh is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Hepatology and Pharmacology, having authored 76 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Gastric Cancer Management and Outcomes (9 papers), Inflammatory mediators and NSAID effects (9 papers), Pancreatic and Hepatic Oncology Research (9 papers), Colorectal and Anal Carcinomas (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Pharmacology (259 citations), Physiology (75 citations), Oncology (346 citations), Applied Microbiology and Biotechnology (25 citations) and Cell Biology (200 citations). Adel Kardosh has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Axel H. Schönthal, Thomas C. Chen, Nicos A. Petasis, Peter Pyrko, Florence M. Hofman, Jasim Uddin, Stan G. Louie, Encouse B. Golden, Kevin J. Gaffney and Weijun Wang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Annals of Surgical Oncology, Cancer Biology & Therapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.